Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled for cataract surgery~Exclusion Criteria:~* Known hypersensitivity to bromfenac and salicylates

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bromfenac (Type: EXPERIMENTAL): Bromfenac ophthalmic solution 0.09%, dosed 1 drop daily
- Placebo (Type: PLACEBO_COMPARATOR): Placebo, dosed 1 drop daily

Based on this trial design, predict the completion outcome and termination type (if applicable).